Category: Patent Legislation

  • By Donald Zuhn — Last fall, Rep. Robert Latta (R-OH) (at right) introduced legislation in the House (H.R. 6352) that would have amended 35 U.S.C. § 292 to modify the penalty for false marking (see "New False Marking Bill Introduced in the House").  On January 7, Rep. Latta reintroduced the bill, now H.R. 243, in…

  •     By Donald Zuhn — In an opinion piece published on POLITICO last week, the new Chairman of the House Judiciary Committee, Rep. Lamar Smith (R-TX) (at right), laid out Congress' resolutions for 2011 ("Judiciary panel's New Year's resolve").  In particular, Chairman Smith noted that Congress (or at least the Republican-controlled House of Representatives) "resolved to…

  • By Donald Zuhn — Reflecting upon the events of the past twelve months, Patent Docs presents its fourth annual list of top biotech/pharma patent stories.  For 2010, we identified a dozen stories that were covered on Patent Docs last year that we believe had (or are likely to have) the greatest impact on biotech/pharma patent…

  • By Donald Zuhn — On Tuesday, the House of Representatives sent H.R. 628, which would establish a pilot program in certain U.S. district courts to encourage enhancement of expertise in patent cases among district judges, to the President for his signature.  The House had agreed to a Senate amendment to the bill on December 17,…

  • By Donald Zuhn — On September 29, Rep. Robert Latta (R-OH) (at right) introduced a bill in the House (H.R. 6352) that would amend Title 35 to modify the penalty for false marking, as well as make other changes to the false marking statute.  The bill, entitled the Patent Lawsuit Reform Act of 2010, was…

  • By Donald Zuhn — With fall fast approaching, it appears that patent reform legislation has returned from a lengthy summer vacation and once again is a topic of conversation, at least in the Senate.  In the latest effort to secure passage of the Senate patent reform bill (S. 515), a group of 25 Senators led…

  •     By Donald Zuhn — The journal Medical Innovation & Business has devoted its summer issue, which was released last month, to an examination of the effects of patent reform on medical innovation.  The periodical has assembled a group of recognizable and respected members of the patent community to tackle various aspects of the topic. …

  •     By Kevin E. Noonan — "Politics," according to Otto von Bismarck, "is the art of the possible."  And thus it is possible that a patent reform bill will, against all odds, be passed by this session of Congress.  But that is only if Senator Patrick Leahy (D-VT) (at right) is successful in sneaking the…

  •     By Donald Zuhn — In the face of strong opposition, the House of Representatives declined to bring a bill that would provide the U.S. Patent and Trademark Office with fee-setting authority to the floor for a vote during today's legislative business session.  While the text of the bill had not been made available as…

  •     By Donald Zuhn — Earlier today, the Intellectual Property Owners Association (IPO) reported that new legislation that would provide the U.S. Patent and Trademark Office with fee-setting authority will be brought to the floor of the House of Representatives for a vote during its legislative business session on Tuesday.  The bill, entitled the "Patent…